Zerivitz, Kenn L. External Entity

Publications

Sort by

Selected publications

  • Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors.  Clinical cancer research : an official journal of the American Association for Cancer Research2011 Academic Article GET IT
    Times cited: 289

Other